← Stocks · KPRX record
Signal record & history · Trifecta Signals
Kiora has been flagged by the Trifecta screener 1 time since 2022. 1 signal confirmed; the median confirmed signal is down 99.3% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Jan 2022 · Latest Jan 2022 · Confirmed 1 of 1 Early · Latest close in the chart data: Wed, Nov 4, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since January 2022, Kiora has had one Early signal, one confirmed. Its one decided signal gained +10% within 90 days, and it did not finish ahead of the S&P 500 since confirmation.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for KPRX and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Kiora Pharmaceuticals is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. At a market value of about $7.7 million, it sits in the small-cap group.
Kiora Pharmaceuticals’ standout Trifecta run followed a January 2022 confirmation, falling about 31% over the next 90 days. For classification, revenue was shrinking by about 100% at the time, and it sat in the mid-cap group when that signal fired.
At the most recent close, Wednesday, November 4, the shares finished at $1.66, down 4.0% on the day. Over the past week, the shares have traded in a range between about $1.56 and $1.76.
